Situation: A large pharma company has a rheumatoid arthritis (RA) treatment that has been on the market for 3 years. Although the brand has a strong scientific foundation and post-launch research studies have shown it to be a clinically superior product, it is gradually losing market share to competitors and facing decreasing revenues. The company asks for inVentiv's help in regaining lost ground.
Insight: After conducting research with physicians and patients, inVentiv discovers that although patients who stay on the brand generally have positive outcomes, many patients drop off the treatment during the first few weeks. The poor persistency is linked to the brand's side effects, which are generally worse during the first several weeks of treatment. After a patient drops off the brand or complains to their doctor about the side effects, the physician typically prescribes a competing product.
Solution: inVentiv designs a multi-pronged approach to educate physicians and patients about managing the side effects associated with the brand, and to encourage patient adherence. Components of the program are as follows:
Results: Improved education leads to better dialogue between physicians and patients about RA treatment. Prescription rates, sales revenue, and patient adherence are positively impacted.